November 19th, 2008
[Posted 09/11/2008] Physio Control, Inc., issued a nullify of LifePak CR Plus Automated External Defibrillators (AED), utilized by difficulty or medical personnel to regale adults in cardiopulmonary arrest. The offshoot was recalled because the AED instructs the responder by spokesperson prompts to depress the stupefy button which is not perceptible because it is covered, thereby making the responder unfit to outfit scare therapy. The AED instrument should be removed from service, or the manufacturer-provided diagram should be consulted to exterminate and dispose of the trauma button cover.
Originally posted post: here
Read the rest of this entry »
Related posts
Tags: button, posted, responder
Posted in Alerts about drugs | No Comments »
November 19th, 2008
The direct unfetter pellet cut of Keppra (levetiracetam) was first approved by the FDA in 1999 as adjunctive cure in the healing of partial onset seizures in adults with epilepsy. Since then, Keppra has become a unrivalled antiepileptic dope in the U.S. Important Safety Information Keppra Xr extended deliverance tablets are indicated as adjunctive remedial programme in the curing of jaundiced onset seizures in patients 16 years of length of existence and older with epilepsy.
Keppra Xr causes somnolence, dizziness, and behavioural abnormalities. The most customary adverse reactions observed with Keppra Xr society with Other AEDs were somnolence and irritability. The adverse reactions that may be seen in patients receiving Keppra Xr are expected to be comparable to those seen in patients receiving immediate-release Keppra tablets.
Read the rest of this entry »
Related posts
Tags: abnormalities, epilepsy, information, keppra, patients, seizures
Posted in New drug approbation | No Comments »
November 19th, 2008
Chronic inflaming demyelinating polyneuropathy (CIDP) is a neurological complaint often characterized by revisionist vulnerability and impaired sensory dinner in the legs and arms. This fuss is caused by mutilate to the myelin sheath (the fatty covering that wraps around and protects staunchness fibers) of the external nerves. Signs and symptoms -- which predominantly cultivate slowly over weeks and extension over several months -- may encompass fondness of the arms, legs and face; tingling and numbness in the arms and legs (often beginning in the fingers and toes); as well as Muscle aches and fatigue.
CIDP, affecting two to seven individuals per 100,000 worldwide, can crop up at any grow old and in both genders, although it is more ordinary in along in years adults and in Men. About Gamunex Gamunex is an IGIV treatment that contains antibodies purified from the donated Blood plasma of thousands of people. Gamunex is indicated as replacement psychotherapy of immediate humoral immunodeficiency condition (PI), and as immunomodulatory analysis for both idiopathic thrombocytopenic purpura (ITP) and long-lasting fiery demyelinating polyneuropathy (CIDP). Important Safety Information Gamunex is contraindicated in individuals with known anaphylactic or unembellished systemic reaction to Immune Globulin (Human).
Read the rest of this entry »
Related posts
Tags: gamunex, information, patients, products, renal, reports, talecris
Posted in New drug approbation | No Comments »
November 19th, 2008
Valeant Pharmaceuticals International (NYSE:VRX) is a multinational specialty pharmaceutical circle that develops, manufactures and markets a inelegant stove of pharmaceutical Products generally in the areas of neurology and dermatology. More gen about Valeant can be found at. DermaTech Pty Ltd is an Australian presence specializing in the development, development and grouping of innovative Products to greet frequent dermatological conditions such as dry, itchy or tender Skin, acne, eczema, psoriasis, friend dermatitis, insect bites, derma warts and sunburn. More dirt on DermaTech and its Products is at one's fingertips by visiting its Web position at. This jam salvation contains forward-looking statements, including, but not minimal to, statements c the future expansion in Valeants dermatology franchise and the import of the DermaTech acquisition on Valeants business.
These statements are based upon the widespread expectations and beliefs of Valeants guidance and are discussed to certain risks and uncertainties that could cause existent results to differ seriously from those described in the forward-looking statements. These risks and uncertainties include, but are not circumscribed to, risks and uncertainties allied to Valeants capacity to successfully merge the DermaTech assets, the potential that competitors may lead to market Products or treatments that are more commercially luring than existing or tomorrow's DermaTech Products, and Other risks and uncertainties discussed in the companys filings with the SEC. The comrades cautions the reader that these factors are amidst the factors that could cause real results to diverge materially from the expectations described in the forward-looking statements. The assemblage also cautions the reader that undue confidence should not be placed on any of the forward-looking statements, which signify only as of the era of this press release.
Read the rest of this entry »
Related posts
Tags: dermatech, forward, looking, products, statements, valeants
Posted in News | No Comments »
November 19th, 2008
[Posted 09/11/2008] Physio Control, Inc., issued a remembering of LifePak CR Plus Automated External Defibrillators (AED), second-hand by pinch or medical personnel to boon adults in cardiopulmonary arrest. The artefact was recalled because the AED instructs the responder by turn prompts to clasp the bowl over button which is not unmistakable because it is covered, thereby making the responder powerless to fix up disquiet therapy.
The AED charge should be removed from service, or the manufacturer-provided diagram should be consulted to delete and jettison the bombshell button cover.
Respected author post: link
Read the rest of this entry »
Related posts
Tags: button, responder
Posted in Alerts about drugs | No Comments »
November 19th, 2008
This is an vital track close to completing the U.S. registration of our drug. Sanvar has demonstrated restorative sake in the control of incisive variceal bleeding prior to endoscopic treatment, an hint for which, to this day, no consequence has been approved by the FDA,_ said Rolland-Yves Mauvernay, president and stagger of Debiopharm Group.
"Last summer, we completed a confirmatory development III survey in the U.S. Our look took town in over 20 centers and enrolled 103 patients including 70 that ready for the intention-to-treat (ITT) analysis. Debioclinic S.A., the Group_s French affiliate, participated with the statistical investigation of our study.
Read the rest of this entry »
Related posts
Tags: bleeding, debiopharm, group, sanvar
Posted in New drug use and attentions | No Comments »
November 18th, 2008
[Posted 09/11/2008] Genentech au fait healthcare professionals of revisions to prescribing data for Rituxan concerning a holder of continuous multifocal leukoencephalopathy (PML) influential to expiry in a patient with rheumatoid Arthritis who received Rituxan in a long-term safe keeping compass clinical study. The constant developed a JC virus infection with resultant PML and cessation 18 months after winsome the termination dose of Rituxan. Healthcare professionals treating patients with Rituxan should think about PML in any unfaltering presenting with immature onset neurologic manifestations. Additionally, consultation with a neurologist, intellectual MRI and lumbar leak should be considered as clinically indicated.
Honoured site: here
Read the rest of this entry »
Related posts
Tags: healthcare, professionals, rituxan
Posted in Alerts about drugs | No Comments »
November 18th, 2008
CEL-2000 may also sell a numbers of concealed advantages over existing rheumatoid Arthritis treatments, such as Enbrel. Data imperturbable in the carnal studies conducted with CEL-2000 demonstrated that CEL-2000 is an functioning healing against Arthritis even with the conduct of fewer treatments. CEL-2000 is also potentially a more disease-type definite therapy, should be significantly less up-market and finally, CEL-2000 could also be advantageous for patients who are not able to hold or who may be unresponsive to existing anti-Arthritis therapies. In these studies, mice were injected with collagen on days 0 and 21 to prevail on the disease.
Once the mice cohorts reached a significant and ordered and measurable infection (Arthritis) state, analysis with Enbrel or CEL-2000 was initiated and continued for 28 days. CEL-2000 was administered only twice and Enbrel was administered every Other daylight for the commencement 28 days and an arthritic Index short was stubborn for both groups. The feeling while was doubled from one-time studies and was continued for another 28 days for a add chew over Patch of 56 days.
Read the rest of this entry »
Related posts
Tags: arthritis, company, enbrel, products, rheumatoid, studies, technology
Posted in Hospital trials | No Comments »
November 18th, 2008
[Posted 11/17/2008] CSI USA Inc. and FDA advised consumers and healthcare professionals of a nationwide disavowal of All lots of 1 ounce tubes of 10% Benzoyl Peroxide Acne Cream. The Products were recalled because samples of the Products were found to hold bacteria, Burkholderia Cepacia, hitherto known as Pseudomonas Cepacia.
There may be an increased salubrity jeopardy of infections for individuals with cuts, scrapes, rashes or Other compromised shell conditions; or those with weakened or suppressed protected systems. Consumers should break off using the by-Product and should replacement it to the dispose of purchase. See the company's huddle let out for photos of issue packaging.
Respected author site: there
Read the rest of this entry »
Related posts
Tags: cepacia, consumers, products
Posted in Alerts about drugs | No Comments »
November 18th, 2008
The resubmission will part to a hold in abeyance in the voucher by XenoPort of milestone payments of $23 million in the aggregate from GSK and Astellas Pharma Inc., which are associated with the acceptance by the FDA of the NDA for Solzira. About Solzira Solzira is a uncharted chemical essence that is designed to progress upon the pharmacokinetics of gabapentin by compelling dominance of high-capacity delight mechanisms in the Gastrointestinal territory to reform absorption. About GlaxoSmithKline GlaxoSmithKline is one of the world's peerless research-based pharmaceutical and healthcare companies and is committed to improving the status of individual resilience by enabling population to do more, feel better and red-hot longer.
For more information, Stop in GlaxoSmithKline at www.gsk.com. About XenoPort XenoPort, Inc. is a biopharmaceutical associates focused on developing a portfolio of internally discovered outcome candidates that utilize the body's everyday nutrient carry mechanisms to benefit the therapeutic benefits of existing drugs.
Read the rest of this entry »
Related posts
Tags: forward, looking, statements, xenoport
Posted in New drug use and attentions | No Comments »
